Correction: Combination of betulinic acid and EGFR‑TKIs exerts synergistic anti‑tumor effects against wild‑type EGFR NSCLC by inducing autophagy‑related cell death via EGFR signaling
- PMID: 40223044
- PMCID: PMC11995596
- DOI: 10.1186/s12931-025-03223-8
Correction: Combination of betulinic acid and EGFR‑TKIs exerts synergistic anti‑tumor effects against wild‑type EGFR NSCLC by inducing autophagy‑related cell death via EGFR signaling
Figures


Erratum for
-
Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway.Respir Res. 2024 May 20;25(1):215. doi: 10.1186/s12931-024-02844-9. Respir Res. 2024. PMID: 38764025 Free PMC article.
Similar articles
-
Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway.Respir Res. 2024 May 20;25(1):215. doi: 10.1186/s12931-024-02844-9. Respir Res. 2024. PMID: 38764025 Free PMC article.
-
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells.Thorac Cancer. 2021 Apr;12(8):1210-1218. doi: 10.1111/1759-7714.13902. Epub 2021 Mar 3. Thorac Cancer. 2021. PMID: 33656275 Free PMC article.
-
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines.Oncol Rep. 2015 Jan;33(1):239-49. doi: 10.3892/or.2014.3583. Epub 2014 Nov 3. Oncol Rep. 2015. PMID: 25370413
-
Overall survival in stage IV EGFR mutation‑positive NSCLC: Comparing first‑, second‑ and third‑generation EGFR‑TKIs (Review).Int J Oncol. 2021 Feb;58(2):171-184. doi: 10.3892/ijo.2021.5168. Epub 2021 Jan 7. Int J Oncol. 2021. PMID: 33491758 Review.
-
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review).Int J Oncol. 2021 Nov;59(5):90. doi: 10.3892/ijo.2021.5270. Epub 2021 Sep 24. Int J Oncol. 2021. PMID: 34558640 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous